While long-term studies on injectable weight loss medications are ongoing, no major long-term risks have been definitively identified yet. However, it’s important to remember that these medications are relatively new. One known factor is that weight regain is a significant risk after stopping treatment, as per NICE guidelines. However, our programme aims to address this challenge by promoting long-term success. We focus on building positive lifestyle changes and patient education to help individuals maintain a healthy weight after treatment.
